Literature DB >> 23035197

Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Yanping Luo1, Yanning Ma, Qiang Zhao, Leili Wang, Ling Guo, Liyan Ye, Youjiang Zhang, Jiyong Yang.   

Abstract

In order to obtain a better molecular understanding of recurrent urinary tract infection (RUTI), we collected 75 cases with repeatedly occurring uncomplicated UTI. The genetic relationships among uropathogenic Escherichia coli (UPEC) isolates were analyzed by pulsed-field gel electrophoresis. While 39 (52%) of the RUTI cases were defined as "persistence" of the same strain as the primary infecting strain, 36 (48%) were characterized by "reinfection" with a new strain that is different from the primary strain. We then examined the antimicrobial susceptibilities and phylogenetic backgrounds of 39 persistence and 86 reinfection UPEC isolates, and screened 44 virulence factor (VF) genes. We found that isolates had significant differences in the following: placement in phylogenetic group B2 (41% versus 21%; P = 0.0193) and the presence of adhesin genes iha (49% versus 28%; P = 0.0233) and papG allele I' (51% versus 24%; P = 0.003), iron uptake genes fyuA (85% versus 58%; P = 0.0037), irp-2 (87% versus 65%; P = 0.0109), and iutA (87% versus 58%; P = 0.0014), and an aggregate VF score (median, 11 versus 9; P = 0.0030). In addition, 41% of persistence strains harbored three adhesin genes simultaneously, whereas 22% of reinfection isolates did (P = 0.0289). Moreover, 59% versus 29% (P = 0.0014) of persistence and reinfection isolates contained seven types of iron uptake genes. Taken together, the antimicrobial susceptibilities of UPEC isolates had little effect on the RUTI. Compared with reinfection strains, persistence UPEC isolates exhibited higher VF scores and carried more VF genes than may be involved in the development and progression of RUTI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035197      PMCID: PMC3502954          DOI: 10.1128/JCM.02086-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Recurrent urinary tract infections in postmenopausal women.

Authors:  R Raz; Y Gennesin; J Wasser; Z Stoler; S Rosenfeld; E Rottensterich; W E Stamm
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up.

Authors:  U M Kärkkäinen; R Ikäheimo; M L Katila; A Siitonen
Journal:  Scand J Infect Dis       Date:  2000

5.  Risk factors for recurrent urinary tract infection in young women.

Authors:  D Scholes; T M Hooton; P L Roberts; A E Stapleton; K Gupta; W E Stamm
Journal:  J Infect Dis       Date:  2000-08-31       Impact factor: 5.226

Review 6.  Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Authors:  M A Mulvey; J D Schilling; J J Martinez; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet.

Authors:  Efrain M Ribot; M A Fair; R Gautom; D N Cameron; S B Hunter; B Swaminathan; Timothy J Barrett
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

8.  Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis.

Authors:  Kylie E Rodriguez-Siek; Catherine W Giddings; Curt Doetkott; Timothy J Johnson; Mohamed K Fakhr; Lisa K Nolan
Journal:  Microbiology       Date:  2005-06       Impact factor: 2.777

9.  Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants.

Authors:  Forough L Nowrouzian; Agnes E Wold; Ingegerd Adlerberth
Journal:  J Infect Dis       Date:  2005-03-02       Impact factor: 5.226

10.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.

Authors:  B Foxman; L Zhang; P Tallman; K Palin; C Rode; C Bloch; B Gillespie; C F Marrs
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

View more
  23 in total

Review 1.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

2.  One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.

Authors:  Henry L Schreiber; Caitlin N Spaulding; Karen W Dodson; Jonathan Livny; Scott J Hultgren
Journal:  Ann Transl Med       Date:  2017-01

3.  Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.

Authors:  Valerie P O'Brien; Matthew S Joens; Amanda L Lewis; Nicole M Gilbert
Journal:  J Vis Exp       Date:  2020-12-04       Impact factor: 1.355

4.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Authors:  Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

Review 5.  From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.

Authors:  Jennifer A Silverman; Henry L Schreiber; Thomas M Hooton; Scott J Hultgren
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

6.  Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.

Authors:  Z Hojabri; M Mirmohammadkhani; F Kamali; K Ghassemi; S Taghavipour; O Pajand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-27       Impact factor: 3.267

7.  Whole-genome-sequence-based characterization of an NDM-5-producing uropathogenic Escherichia coli EC1390.

Authors:  Tran Thi Dieu Thuy; Hsu-Feng Lu; Pei-Yun Kuo; Wei-Hung Lin; Tzu-Ping Lin; Yi-Tzu Lee; Tran Thi Thuy Duong; Ming-Cheng Wang; Yi-Hong Lee; Li-Li Wen; Yu-Chen Chen; Cheng-Yen Kao
Journal:  BMC Microbiol       Date:  2022-06-06       Impact factor: 4.465

8.  Purification of Intracellular Bacterial Communities during Experimental Urinary Tract Infection Reveals an Abundant and Viable Bacterial Reservoir.

Authors:  Suhanya Duraiswamy; Jacqueline L Y Chee; Siyi Chen; Enjun Yang; Kristin Lees; Swaine L Chen
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

9.  Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.

Authors:  Wei-Hung Lin; Chin-Chung Tseng; An-Bang Wu; Yu-Tzu Chang; Te-Hui Kuo; Jo-Yen Chao; Ming-Cheng Wang; Jiunn-Jong Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-21       Impact factor: 3.267

10.  Comparison of Antibiotic Resistance and Virulence Factors among Escherichia coli Isolated from Conventional and Free-Range Poultry.

Authors:  Vanessa L Koga; Sara Scandorieiro; Eliana C Vespero; Alexandre Oba; Benito G de Brito; Kelly C T de Brito; Gerson Nakazato; Renata K T Kobayashi
Journal:  Biomed Res Int       Date:  2015-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.